Sai Life Sciences Limited has informed the Exchange regarding Notice of 26th Annual General Meeting to be held on Thursday, September 11, 2025 at 10:30 AM (IST)
SAILIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sai Life Sciences has informed the exchanges about its 26th Annual General Meeting scheduled for Thursday, September 11, 2025 at 10:30 AM IST, to be held via Video Conference or other audio-visual means. The AGM notice forms part of the company's first Annual Report as a publicly listed entity following its December 2024 IPO, which was subscribed 10.27 times and listed at a premium of 18.4% on NSE and 20.22% on BSE. The Annual Report highlights FY25 financials: revenue of ₹1,695 crore (up 16% year-on-year), EBITDA of ₹425 crore (up 42%), and profit after tax of ₹170 crore (up 105%). The company, a CRDMO serving global pharma and biotech firms, has 300+ innovator clients including 18 of the top 25 big pharma, 3,400+ employees, and a revenue mix of 37% CRO and 63% CDMO. The notice has been sent electronically to all shareholders and is available on the company's website.
This is a routine regulatory filing regarding the AGM. For shareholders, this is the first AGM since the company's listing in December 2024, where they can participate in voting on resolutions and engage with management. The strong FY25 financial performance disclosed in the accompanying annual report reinforces the company's growth trajectory, though the AGM itself is unlikely to trigger an immediate stock price reaction.